English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    R. A. Rzayeva

    MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ITS COMBINATION WITH METABOLIC SYNDROME


    About the author: R. A. Rzayeva
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The purpose of the study was to assess of the frequency of multifocal atherosclerosis and plural atherosclerotic plaques in the different vessels of patients with type 2 diabetes mellitus and its combination with metabolic syndrome. Results showed that 12.02 % of patients with diabetes mellitus without metabolic syndrome had multifocal atherosclerosis with simultaneous damage of 2 vessels, in patients with diabetes mellitus+metabolic syndrome – 22.75 % (p<0.001). Significantly more frequent cases of multifocal atherosclerosis with simultaneous involvement of several vascular beds in patients with diabetes mellitus without metabolic syndrome and with diabetes mellitus+metabolic syndrome in contrast to patients without diabetes and metabolic syndrome (p<0.01). Thus, a significant effect of diabetes mellitus on the rapid development and progression of atherosclerosis, which is exacerbated with the accession of the metabolic syndrome, has been demonstrated.
    Tags atherosclerotic plaques,type 2 diabetes mellitus,metabolic syndrome,arterial hypertension
    Bibliography
    • Avilova MV, Kosmacheva YeD. Multifokalnyy ateroskleroz: problema sochetannogo ateroskleroticheskogo porazheniya koronarnogo i brakhiotsefalnogo basseynov. Kreativnaya kardiologiya. 2013; 1: 5–13. [in Russian]
    • Genkel VV, Salashenko AO, Shamaeva TN. Ateroskleroz perifericheskikh arteriy u bolnykh ishemicheskoy boleznyu serdtsa i sakharnym diabetom 2 tipa. Therapeutic Archive. 2019; 91 (10): 54–62. DOI: 10.26442/00403660.2019.10.000106 [in Russian]
    • Gracheva SA, Biragova MS, Glazunova AM, Klefortova II, Shamkhalova MSh, Dzhavelidze MI, et al. Faktory riska i prognosticheskoye znacheniye multifokalnogo ateroskleroza u bolnykh s sakharnym diabetom. Ter Arkh. 2014;86(10):20–6. PMID: 25509887 [in Russian]
    • Puzyrov GS, Lyakhovskyi VI, Shepitko VI, Sydorenko AV. Morfolohichne obgruntuvannya zastosuvannya poetapnoyi dozovanoyi balonnoyi anhioplastyky u porivnyanni z standartnoyu metodykoyuu khvorykh z ishemichnoyu formoyu syndromu diabetychnoyi stopy. Svit medytsyny ta biolohiyi. 2020; 3 (73): 87–91. DOI: 10.26724/2079-8334-2020-3-73-87-91. [in Ukrainian]
    • Sedykh DY, Kazantsev AN, Tarasov RS, Kashtalap VV, Volkov AN, Grachev KI, et al. Prediktory progressiruyushchego techeniya mnogoochagovogo ateroskleroza u bolnykh infarktom miokarda. Kardiologiya. 2019;59(5):36–44. doi: 10.18087/cardio.2019.5.10257. [in Russian]
    • Sumin AN, Bezdenezhnykh NA, Bezdenezhnykh AV, Ivanov SV, Barbarash OL, Barbarash LS. Vliyaniye sakharnogo diabeta 2 tipa na rasprostranennost mnogoochagovogo ateroskleroza u bolnykh ishemicheskoy boleznyu serdtsa. Kardiologiia. 2012;52(11):33–41. [in Russian]
    • Bonaca MP, Gutierrez JA, Cannon C, et al. Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial. Lancet Diabetes Endocrinol. 2018;6(12):934–43. doi:10.1016/S2213-8587(18)30290-0.
    • Cavender MA, Steg PG, Smith SC Jr, Eagle K, Ohman EM, Goto S, et al. REACH Registry Investigators. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Conti -nued Health (REACH) Registry. Circulation. 2015;132:923-31. doi:10.1161/CIRCULATIONAHA.114.014796
    • Classification of diabetes mellitus. WHO. Geneva. 2019. 36p. https://apps.who.int/iris/bitstream/handle/10665/325182/ 9789241515702-eng.pdf
    • Grozdinski L, Stankev MM, Doganov A. Ultrasound screening of multifocal atherosclerosis: markers for coronary heart disease. Journal of Geriatric Cardiology. 2009: 6 (1): 31–37.
    • Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J Mol Sci. 2020 Mar 6;21(5):1835. doi: 10.3390/ijms21051835.
    • Protus BM. BMJ Best Practice. J Med Libr Assoc. 2014 Jul;102(3):224–5. doi: 10.3163/1536-5050.102.3.020.
    • Skorodumova EG, Kostenko VA, Skorodumova EA, Siverina AV, Rysev AV. Medical model of the diagnosis of multifocal atherosclerosis in patients with stable ischemic heart disease. European Heart Journal. 2021; 42(1), ehab724.3278. doi:10.1093/eurheartj/ehab724.3278.
    • Stojanović SD, Fiedler J, Bauersachs J, et al. Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis. Eur Heart J. 2020;41(31):2983–96. doi:10.1093/eurheartj/ehz919.10.
    • Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun;71(6):1269–1324. doi: 10.1161/HYP.0000000000000066.
    Publication of the article «World of Medicine and Biology» №4(82), 2022 year, 148-152 pages, index UDK 616.13-004.6; 616.379-008.64
    DOI 10.26724/2079-8334-2022-4-82-148-152